TC

15/10/2019 09:35

{I-bank focus}CS raises Jinxin Fertility (01951) to HK$15.12

   Credit Suisse raised its target price for Jinxin Fertility (01951) to HK$15.12 from HK$12.25 and maintained its "outperform" rating.
  The research house said the target price hike was based on management's reiteration on M&A expansion, increased margin from optimised revenue mix in the Xinan hospital, and the positive impact from restructuring in the Zhongshan hospital.
  Jinxin reiterated its ability to maintain high success rates at each of its hospitals, achieving 20% top-line growth across its hospital network and continuing to seek M&A opportunities where it can add value to existing businesses and that it will focus on targets that have strong regional market potential.
  Credit Suisse lifted its 2019-21 EPS forecasts by 3-7%.

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【嚴正聲明】《經濟通》呼籲公眾提高警覺留意偽冒《經濟通》投資群組

如何分辨問米是否真實?通靈問事用什麼工具都可以?靈靈法即場示範通靈!

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

貨幣攻略

大國博弈

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

夏天養生食療

消委會報告

山今養生智慧

輕鬆護老